Contact Lenses/Eye Wear News

The Cooper Companies Inc. announced Wednesday that has acquired Sauflon Pharmaceuticals Ltd. for approximately $1.2 billion.

Alcon Laboratories Inc. submitted a written statement to the Senate Subcommittee on Antitrust Competition Policy and Consumer Rights regarding its unilateral pricing policy, explaining its rationale and anticipated benefits.

Alden Optical announced that ABB Optical Group will be its only distributor partner, effective Sept. 1.

SynergEyes announced that it has raised $12 million to accelerate expansion of its contact lenses for patients with astigmatism, presbyopia and irregular corneas.

The Senate Subcommittee on Antitrust Competition Policy and Consumer Rights held a hearing July 30 to explore contact lens pricing strategies initiated recently by contact lens manufacturers that would affect retail price competition, Sen. Amy Klobuchar (D-Minn.) said as she presided over the proceedings.

To say today’s health care provider is challenged is a bit of an understatement. We deal with the human body, which is both incredibly intricate and oft times unpredictable. We deal with individuals whose emotions, intellect and value systems run the gamut. In addition, if patient care alone is not challenging enough, we spend a good portion of our days navigating an increasingly burdensome regulatory environment. Just when we feel as though we have reached some level of decorum, change happens – often, big change.

Researchers are developing computer algorithms to compensate for an individual’s visual impairment and creating vision-correcting displays that enable users to see the display clearly without glasses or contact lenses.

Researchers at National Taiwan University Hospital, Hsin Chu branch, and National Chiao-Tung University have developed a wearable device to detect diabetic autonomic neuropathy, a complication of diabetes, sooner, according to a press release from the Optical Society.

NanoVision Group announced it has entered into a manufacturing and distribution agreement with OVI Lens, as well as a collaboration for new technological development.

A review recently published by Optometry & Vision Science discussed techniques to better manage older patients who are at risk for falling, one of which is to avoid dramatic changes in spectacle lens prescriptions.